Severe myoclonus, generalized seizures, and marked stupor occurred in a 39-year-old woman with chronic renal insufficiency after one week of moxalactam 2 g iv q8h. Moxalactam serum levels far exceeded the recommended therapeutic range. The drug half-life was 17 hours (normal 1.9). Excessively high levels of moxalactam, which penetrates the blood-brain-barrier relatively easily, may provoke seizures and encephalopathy.
SnavelySRHodgesGR. The neurotoxicity of antibacterial agents. Ann Intern Med1984; 101: 92–104.
2.
YoshiokaHNambuHFujitaMUeharaH. Convulsion following intrathecal cephaloridine. Infection1975; 3: 123–4.
3.
GardnerMEFritzWLHylandRN. Antibiotic-induced seizures: A care attributed to cefazolin and a review of the literature. Drug Intell Clin Pharm1978; 12: 268–71.
4.
BechtelTPSlaughterRLMooreTD. Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm1980; 37: 271–3.
5.
YostRLLeeJDO'LearyJP. Convulsions associated with sodium cefazolin: A case report. Am Surg1977; 43: 417–20.
6.
MandellGLSandeMA. Antimicrobial agents: Penicillins and cephalosporins. In: GoodmanLSGilmanA, eds. The pharmacologic basis of therapeutics. 6th ed.New York: Macmillan Publishing Co., 1980: 1126–61.
7.
SchaadUBMcCrackenGHThrelkeldNThomasML. Clinical evaluations of a new broad spectrum oxa-beta-lactam antibiotic, moxalactam, in neonatals and infants. J Pediatr1981; 98: 129–36.
8.
TraserGMPanwalkerAPMalowJBPorembskiPERamirezCAZarFA. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency. Chemotherapy1981; 27: 287–95.
9.
McKeeKTWrightPFGreggCRStrattonCW. Initial evaluation of kinetics and efficacy of moxalactam in neonatal systemic gram-negative bacterial disease. Curr Ther Res Clin Exp1980; 28: 603–10.
10.
Package insert. Moxam (moxalactam disodium). PA 1201 AMP. Indianapolis: Eli Lilly and Company, 1982.
